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Modulation of KV7 Channel
Deactivation by PI(4,5)P2
Carlos A. Villalba-Galea*
Department of Physiology and Pharmacology, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA,
United States
The activity of KV7 channels critically contributes to the regulation of cellular electrical
excitability in many cell types. In the central nervous system, the heteromeric KV7.2/KV7.3
channel is thought to be the chief molecular entity giving rise toM-currents. These K+-currents
as so called because they are inhibited by the activation of Gq protein-coupled muscarinic
receptors. In general, activation of Gq protein-coupled receptors (GqPCRs) decreases the
concentration of the phosphoinositide PI(4,5)P2 which is required for KV7 channel activity. It
has been recently reported that the deactivation rate of KV7.2/KV7.3 channels decreases as a
function of activation. This suggests that the activated/open channel stabilizes as activation
persists. This property has been regarded as evidence for the existence of modal behavior in
the activity of these channels. In particular, it has been proposed that the heteromeric KV7.2/
KV7.3 channel has at least two modes of activity that can be distinguished by both their
deactivation kinetics and sensitivity to Retigabine. The current study was aimed at
understanding the effect of PI(4,5)P2 depletion on the modal behavior of KV7.2/KV7.3
channels. Here, it was hypothesized that depleting the membrane of P(4,5)P2 would
hamper the stabilization of the activated/open channel, resulting in higher rates of
deactivation of the heteromeric KV7.2/KV7.3 channel. In addressing this question, it was
found that the activity-dependent slowdown of the deactivation was not as prominent when
channels were co-expressed with the chimeric phosphoinositide-phosphatase Ci-VS-TPIP or
when cells were treated with the phosphoinositide kinase inhibitorWortmannin. Further, it was
observed that either of these approaches to deplete PI(4,5)P2 had a higher impact on the
kinetic of deactivation following prolonged activation, while having little or no effect when
activationwas short-lived. Furthermore, it was observed that the action of either Ci-VS-TPIP or
Wortmannin reduced the effect of Retigabine on the kinetics of deactivation, having a higher
impact when activation was prolonged. These combined observations led to the conclusion
that the deactivation kinetic of KV7.2/KV7.3 channels was sensitive to PI(4,5)P2 depletion in an
activation-dependent manner, displaying a stronger effect on deactivation following
prolonged activation.
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INTRODUCTION
To the memory of Louis J. De Felice. A great scientist, an
inspiring mentor, and, simply, a great friend. “…never forget
the physics behind it!”
Voltage-gated, potassium-selective (KV) channels from the
KV7 family are commonly found in the cardiovascular,
gastrointestinal, and nervous systems. They are the main
molecular entities responsible for the so-called M-currents
which are voltage-dependent K+-currents suppressed by the
activity of Gq protein-coupled receptors (GqPCRs) (Brown
and Adams, 1980; Wang et al., 1998; Jentsch, 2000; Cooper,
2012). KV7 channels can display measurable activity at voltages
as negative as −60 mV, making them into critical contributors to
the maintenance of the resting membrane potential (Brown and
Adams, 1980; Wang et al., 1998; Jentsch, 2000; Cooper, 2012;
Linley et al., 2012; Soh et al., 2014; Mastrangelo, 2015; Miceli
et al., 2015). In the nervous system, KV7 channels are critically
involved in controlling excitability in neurons. Indeed, mutations
that impair the normal functioning of KV7 channels cause
neurological disorders such as Benign Familial Neonatal
Seizures (Charlier et al., 1998; Singh et al., 1998; Dedek et al.,
2001; Wuttke et al., 2008), Early Onset Epileptic Encephalopathy
(Weckhuysen et al., 2012; Weckhuysen et al., 2013; Mastrangelo,
2015; Miceli et al., 2015; Abidi et al., 2015), and Peripheral Nerve
Hyperexcitability (Dedek et al., 2001; Wuttke et al., 2007).
The role of KV7 channels in the control of excitability in
electrically active cells have been long recognized. So has been the
potential of these proteins as therapeutic targets for
hyperexcitability disorders such as chronic pain, epilepsy, and
cardiac arrhythmias (Brown and Adams, 1980; Wang et al., 1998;
Jentsch, 2000; Cooper, 2012; Linley et al., 2012; Soh et al., 2014;
Mastrangelo, 2015; Miceli et al., 2015). For instance, Retigabine, a
first-in-class anticonvulsant, was recently used in the U.S. to treat
epileptic disorders in adults (Rundfeldt and Netzer, 2000;
Wickenden et al., 2000). This drug is a KV7 agonist that
facilitates the opening of all members of the KV7 family, except
for KV7.1 (Main et al., 2000; Schenzer et al., 2005; Wuttke et al.,
2005). In the presence of Retigabine, the voltage-dependence for
activation of KV7.2 and KV7.3 channels shifts toward more
negative potentials, reaching up to a −40-mV shift at a
concentration of 100 μM of this drug (Rundfeldt and Netzer,
2000; Wickenden et al., 2000; Main et al., 2000; Rundfeldt and
Netzer, 2000; Tatulian and Brown, 2003; Schenzer et al., 2005;
Wuttke et al., 2005; Gunthorpe et al., 2012; Kim et al., 2015). This
effect made Retigabine into a promising drug for the treatment of
epilepsy and related disorders (Orhan et al., 2012). In spite of the
benefits offered by this agonist, Retigabine usage was limited in
2017 because it causes undesirable side effects in patients that
outweighed its therapeutic prowess (Brodie et al., 2010; Orhan
et al., 2012; Brickel et al., 2012). Nonetheless, the use of Retigabine
has highlighted the potential of targeting KV7 channels in the
treatment of hyperexcitability disorders. Furthermore, Retigabine
remains to be an important research tool and a model KV7 drug.
Two basic premises were considered when defining the
deactivation of KV7.2/KV7.3 channels as the main focus of the
present study. Those premises are: 1) KV7.2/KV7.3 channels
activation is typically slower than the duration of a typical
neuronal action potential (AP). 2) At the usual resting
potential of a neuron, a fraction of these channels has been
already opened. The first premise suggests that during a single
neuronal AP, the increase in the number of activated KV7.2/
KV7.3 channels is negligible (Corbin-Leftwich et al., 2016). The
second premise suggests that the control of excitability by M-
currents is carried out by those KV7.2/KV7.3 channels that are
already open in steady state at the resting potential (Corbin-
Leftwich et al., 2016). Combined, both ideas imply that the
stability of the activated/open channel is critical for the
physiological function of KV7 channels. Therefore, the present
work focuses on studying channel deactivation as a proxy to
understand open channel stabilization.
The signaling lipid phosphatidylinositol-4,5-bisphosphate (PI
(4,5)P2) is essential for the activity of KV7 channels. PI(4,5)P2 is
the most abundant phosphoinositide in the plasma membrane,
constituting about 1% of the total lipids in its inner leaflet (Di
Paolo and De Camilli, 2006). An increase in the concentration of
either PI(4,5)P2 or analogous molecules in the intracellular side
boosts the open probability of the heteromeric KV7.2/KV7.3
channel (Li et al., 2005; Telezhkin et al., 2012a). This implies
that decreasing the concentration of this phosphoinositide
reduces activity by likely reducing the stability of the open
channel as shown by single channels recordings of M-currents
(Marrion, 1993). Following this idea, a set of experiments were
performed in this study to assess the effect of depleting the
plasma membrane of PI(4,5)P2 on the overall kinetics of
deactivation of KV7.2/KV7.3 channels.
One common strategy to experimentally deplete PI(4,5)P2
in cells is to co-express a voltage-sensitive phosphatase (Murata
et al., 2005; Okamura et al., 2018). These membrane proteins
are phosphoinositide-specific phosphatases with voltage-
dependent activity that can efficiently dephosphorylate the
inositol head group of these lipids, effectively depleting the
membrane of PI(4,5)P2 (Villalba-Galea, 2012a; Okamura et al.,
2018). In fact, the strong action of VSPs such as Ci-VSP, Dr-
VSP, and others can degrade PI(4,5)P2 into PI(4)P within a few
hundreds of milliseconds, reversibly abolishing KV7 currents
(Suh and Hille, 2002; Zhang et al., 2003; Villalba-Galea et al.,
2009). This ability of shutting down channel activity when
employing traditional VSPs would make unfeasible to study the
role of PI(4,5)P2 on deactivation following prolonged
depolarizations because there will be no currents left to
study. To circumvent this issue, the chimeric VSP Ci-VS-
TPIP (or hVSP1) was used instead of traditional VSPs such
as Dr-VSP. Ci-VS-TPIP is a chimeric VSP that contains the
voltage-sensor of Ci-VSP and the catalytic domain of the
human VSP known as TPIP (Halaszovich et al., 2012) (a.k.a.
Hs-VSP1 (Halaszovich et al., 2012; Villalba-Galea, 2012b;
Okamura et al., 2018)). It has been already shown that the
activation of Ci-VS-TPIP can effectively decrease KV7.2/KV7.3
channel activity without fully abolishing K+-currents
(Halaszovich et al., 2012). This property made Ci-VS-TPIP
into the ideal VSP for this study.
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Retigabine and Flupirtine are able to mitigate the effect of PI
(4,5)P2 depletion on the activity of KV7.2/KV7.3 and KV7.3
channels (Linley et al., 2012; Kim et al., 2017), while increases
in PI(4,5)P2 levels reduced Retigabine-induced KV7 currents
activation (Soldovieri et al., 2016). Although the mechanism
underlying this action remains unclear, single channel recordings
show that Retigabine increases the lifetime of open state events of
KV7.2/KV7.3 channels, while decreasing the dwelling-time of
closed channel events (Tatulian and Brown, 2003). Further, the
mean-open-time of the isolated pore of KV7.3 channel increases
in the presence of Retigabine (Syeda et al., 2015). Furthermore,
the deactivation rate of both KV7.2/KV7.3 and KV7.3 channels
decreases in the presence of Retigabine (Wickenden et al., 2000;
Corbin-Leftwich et al., 2016; Kim et al., 2017). These
observations likely indicate that Retigabine increases the
stability of the activated/open channel conformation. In
addition, Retigabine can also decrease the deactivation rate of
channels that are open at typical neuronal resting potential
(Corbin-Leftwich et al., 2016). This indicates that Retigabine
acts independently of how channels are being opened.
The slowdown of the deactivation rate of the heteromeric
KV7.2/KV7.3 channel can be attributed to conformational
rearrangements in the protein that occur following activation.
This channel seems to display at least two modes of activity. One
mode is observed immediately after activation, and a second
mode adopted following prolonged activation (Corbin-Leftwich
et al., 2016). Deactivation from this second mode is slower than
from the first mode. One intriguing observation is that the
effectiveness of Retigabine in decreasing the deactivation rate
of KV7.2/KV7.3 channels is higher as the activation is prolonged
(Corbin-Leftwich et al., 2016). This is consistent with the idea
that the distinct deactivation rates correspond to distinct
conformation of the protein such that the action of Retigabine
changes as a function of the deactivation rate. This indicates
that the distinct rates of deactivation in KV7.2/KV7.3 channels
can be modes of activity that have distinct kinetic and
pharmacological properties.
It has been well established that GqPCR regulation of M-
current is mainly mediated by degradation of PI(4,5)P2 (Suh and
Hille, 2002; Zhang et al., 2003; Suh et al., 2004; Delmas and
Brown, 2005; Hernandez et al., 2008a; Hernandez et al., 2009).
Activation of GqPCR leads to the hydrolysis of PI(4,5)P2 by
PLCb into IP3 and DAG. Through this process, the
concentration of PI(4,5)P2 in the plasma membrane is reduced,
decreasing the activity of KV7 channels (Suh and Hille, 2002;
Zhang et al., 2003; Delmas and Brown, 2005; Suh and Hille, 2005;
Suh et al., 2006). The action of PI(4,5)P2 seems to promote KV7
channel opening by boosting open probability (PO) (Delmas and
Brown, 2005; Telezhkin et al., 2012a). Consistently, the activity of
KV7.2-4 channels increases as a function of diC8-PIP2
concentration (Delmas and Brown, 2005); diC8-PIP2 is a
short-aliphatic chain analog of PI(4,5)P2. Single channel
recordings seemingly show that this increase in PO emerges
from both reducing the duration of closed events and increasing
the duration of the open events (Delmas and Brown, 2005). On
the other hand, decreasing the concentration of PI(4,5)P2
decreases that deactivation time constant of KV7.2 channels
(Chen et al., 2015). These observations suggest that the presence
of PI(4,5)P2 is critically needed for the stabilization of open
channel conformations. Yet, decreasing the mean open event
lifetime does not necessarily translate into faster deactivation.
It is important to define the following: Referring to an
activated/open channel means channels sojourning between
conducting (open) and non-conducting (closed) states,
resulting in open and closed events. In other words, the open
probability is higher than zero. While when referring to an open
event, it is simply a single channel conducting ions (open event).
Considering this, if 1) PI(4,5)P2 stabilizes the activated/open
KV7.2/KV7.3 channel and 2) Retigabine is more effective in
decreasing the deactivation rate after prolonged activation, it
can be expected that depletion of PI(4,5)P2 will hamper the
stabilizing action of Retigabine on activated/open KV7.2/KV7.3
channels. To test this hypothesis, the present study analyzed how
PI(4,5)P2 depletion affected the deactivation of KV7.2/Kv7.3
channels expressed in Xenopus oocytes. To decrease the PI(4,5)
P2 content in these cells, two approaches were employed: One,
the co-expression of channels and the chimeric voltage-sensitive
phosphatase Ci-VS-TPIP. Two, treatment of oocytes with the
phosphoinositide-kinase inhibitor Wortmannin. Here, it is
shown that either approach led to increasing the deactivation
rate of KV7.2/KV7.3 channels. Furthermore, it was found that
these treatments reduced the effect of Retigabine on the
deactivation kinetics. These observations indicated that
decreasing PI(4,5)P2 concentration had a higher impact on
channel deactivation following prolonged activation. These
results suggested that KV7.2/KV7.3 channels in their second
mode of activity are more susceptible to PI(4,5)P2 depletion
than those in the first mode of activity. Extrapolating these
results led to postulate that the modal behavior in KV7.2/KV7.3
channels is likely the physiological target for GqPCR-
mediated regulation.
MATERIALS AND METHODS
Preparation of Oocytes and RNA
Injections
RNA preparation, Xenopus laevis oocyte isolation, preparation,
and RNA injection were performed using published methods
(Villalba-Galea et al., 2008; Villalba-Galea et al., 2009; Corbin-
Leftwich et al., 2016). Animal protocols were approved by the
Institutional Animal Care and Use Committees at University of
the Pacific and conform to the requirements in the Guide for
the Care and Use of Laboratory Animals from the National
Academy of Sciences. Ovarian lobules were surgically harvested
from frogs purchased from Xenopus 1 (Dexter, MI, U.S.A.).
Oocytes were maintained at 16–17°C in a solution of (in mM):
100 NaCl, 1 KCl, 2 CaCl2, 1 MgCl2 or MgSO3, 10 HEPES, 2
Pyruvic acid, pH 7.5, and 20–50 mg/L of gentamycin. Results
from many batches of oocytes were combined.
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Electrophysiology
Oocytes were injected with 2 ng of each in vitro–transcribed
cRNA encoding for the human KV7.2 and KV7.3 channels and
0.4 ng of the chimeric construct Ci-VS-TPIP. Injected oocytes
were incubated at 16–17°C for 2–4 days before recordings. The
incubation solution was titrated to pH 7.5 with NaOH and
contained (in mM): 99 NaCl, 1 KCl, 10 HEPES, 1 MgCl2, 1.8
CaCl2 , 1 MgCl2 , 2 Pyruvic ac id , and 20–50 mg/L
of Gentamycin.
Potassium currents were recorded using the Xenopus oocyte
Cut-Open Voltage-Clamp (COVC) technique with a CA-1
amplifier (Dagan Corporation, Minneapolis, MN, U.S.A.). The
external recording solution contained (in mM): 12 KOH, 88 N-
methyl-D-glucamine, 100 Methanesulfonic acid, 10 HEPES, 1
Mg(OH)2, and 2 Ca(OH)2. The intracellular solution contained
(in mM): 100 KOH, 100 Methanesulfonic acid, 10 HEPES, 1 Mg
(OH)2, and 2 EGTA. Both solutions were titrated to pH 7.4 with
Methanesulfonic acid. Retigabine (Alomone Labs, Jerusalem,
Israel) was dissolved at 50 mM in DMSO. Wortmannin
(Tocris Biosicences, Bristol, U.K.) was dissolved at 20 mM in
DMSO. The external solution used for control was added with
0.002%–0.02% (v/v) of DMSO to account for potential effect of
the solvent on the activity of the channels. Borosilicate glass
electrodes (resistance = 0.2–2.0 MW) were filled with a solution
containing (in mM) 1,000 KCl, 10 HEPES and 10 EGTA, at pH
7.4 titrated with KOH.
As previously described, voltage control and current
acquisition was performed using a USB-6251 multi-function
acquisition board (National Instruments, Austin, TX, U.S.A.)
controlled by an in-house program coded in LabVIEW (National
Instruments, Austin, TX, U.S.A.) (details available upon request).
Current signals were filtered at 100 kHz, oversampled at 500
kHz–2 MHz, and stored at 5–25 kHz for offline analysis. Data
were analyzed using a custom Java-based software (details
available upon request) and Origin 2019 (OriginLab,
Northampton, Massachusetts, U.S.A.).
Exponential Fits and Weighted Average
Time Constant
As described in previous studies (Wickenden et al., 2000; Labro
et al., 2012; Villalba-Galea, 2014; Corbin-Leftwich et al., 2016),
the following two-exponential function was fitted to the
deactivating currents:




Where, A1 and A2 are the current amplitude associated with
each component and t1 and t2 are the corresponding time
constants. Fittings were done using Origin 2019 (OriginLab).
When needed, the deactivation weighted average time constant




The fractional amplitude of the second exponential




T-test were calculated for statistical analysis of the
time constants.
It is important to highlight that the two-exponential
equation was not derived from a comprehensive kinetic
model describing the activity of KV7 channels. Instead, it was
selected because it can tightly trace deactivating currents.
Consequently, the parameters yielded from fitting the
equation to such currents can only provide a temporal
description of the deactivation process. Meaningful
assignment of each individual parameter to any physical
process underlying the activity of the channel under study is
therefore very limited and even inadequate.
Molecular Biology
The constructs human KCNQ2 and KCNQ3 in the expression
vector pTLN, encoding KV7.2 and KV7.3 channels, were
linearized with MluI and HpaI (New England Biolabs, Ipswich,
MA, U.S.A.), respectively. The linearized KV7-encoding cDNA
was transcribed using a SP6 RNA polymerase kit (Ambion
mMessage mMachine, Life Technologies, Carlsbad, CA,
U.S.A.). The Ci-VS-TPIP construct in pBSTA was linearized
with NotI and transcribed with a T7 RNA ARCA polymerase kit
(New England Biolabs). The chimeric phosphatase Ci-VS-TPIP
(also known as hVSP1CiV) was built by fusing the voltage-sensing
domain of the Ciona instestinalis voltage-sensitive phosphatase
Ci-VSP (Murata et al., 2005) and the catalytic domain of the
human voltage-sensitive phosphatase known as TPIP or Hs-
VSP1 (Walker et al., 2001). The catalytic selectivity of this
construct has been previously characterized, showing that this
enzyme decreases PI(4,5)P2 in the plasma membrane
(Halaszovich et al., 2012).
RESULTS
Phosphatase Activity Increases the
Deactivation Rate of the KV7.2/KV7.3
Channel
K+-currents were recorded from Xenopus laevis oocytes
injected with cRNA encoding the human KV7.2 and KV7.3
channels. From a holding potential (H.P.) set at −90 mV, K+-
currents were activated by applying 1200-ms test pulses with
amplitudes ranging between −100 mV and +60 mV
(Figure 1). Subsequently, K+-currents deactivated by
applying a −105-mV pulses (Figure 1, red arrow). A two-
exponential function was fitted to the deactivating currents,
yielding two time-constants, namely, t1 and t2. Using these
values, weighted average deactivation time constants (tDEACT)
were calculated and plotted against the amplitudes of the
activating pulse potential (Figure 1A, insert). As previously
reported (Corbin-Leftwich et al., 2016), tDEACT increased as
the amplitude of the activation pulse increased, suggesting
that channels became harder-to-close as the activation was
stronger. A similar profile was observed when co-expressing
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the chimeric phosphatase Ci-VS-TPIP (Figure 1B). However,
tDEACT were smaller at all activating potentials (Figure 1B,
insert). These observations indicated that the action of Ci-VS-
TPIP increases the rate of deactivation of the heteromeric
KV7.2/KV7.3 channels. This suggested that depleting the
membrane of PI(4,5)P2 increases the deactivation rate of
KV7.2/KV7.3 channels.
To assess the effect of the phosphatase activity on activation,
the normalized deactivating (“tail”) current amplitudes were
plotted against the corresponding activating pulse potentials
(Figure 1C). These ITAIL-VPULSE plots showed that the voltage
dependence seemed to be altered by the expression of Ci-VS-TPIP.
However, the effect at more positive potentials is likely due to the
phosphatase own voltage-dependence for its activity; Ci-VS-TPIP
activity increases as the membrane potential is made more positive
(Halaszovich et al., 2012). Considering this, “tail” current
amplitudes were normalized to match the curves at more
negative side of the amplitude-voltage relationship at which the
phosphatase activity is lower. To do so, tail current amplitudes
were normalized with respect to the amplitude observed following
a −10-mV activating pulse. The newly generated ITAIL-VPULSE
plots overlapped at potentials 0 mV and below (Figure 1D),
suggesting that the action of Ci-VS-TPIP had a low impact in the
voltage-dependence for activation of KV7.2/KV7.3 channels.
Phosphatase Activity Hampers the
Activation-Induced Decrease in the
Deactivation Rate
To further assess the effect of Ci-VS-TPIP on the deactivation
kinetics of the heteromeric KV7.2/KV7.3 channel, deactivating K
+-
currents were recorded at −90 mV, following +40-mV pulses of
increasing duration (Figures 2A, B). As before, a two-exponential
function was fitted to the deactivating currents and the yielded time-
constants plotted against the duration of the activating pulse (tPULSE)
(Figures 2C, D). For the channels alone, both t1 and t2 increased as
tPULSE increased (Figures 2C, D, black squares), indicating that
channels became harder-to-close as they were activated for longer
time. Noteworthy, the increase of both t1 and t2 seemed to ensue in
two phases. The first phase occurred within the first 100–200 ms
following activation (Figures 2G, H, black squares) and the second
phase slowly developed thereafter. Likewise, the relative contribution
of second exponential component (fraction of t2) decreased during
the initial phase, remaining relative constant thereafter (Figures 2E,















































FIGURE 1 | K+-currents recorded form Xenopus oocytes expressing the heteromeric KV7.2/KV7.3 channel. (A) From a holding potential (H.P.) set at −90 mV,
channel activity was probed by applying 1200-ms pulses from −100 mV to +60 mV followed by channels deactivation at −105 mV (red arrow). (A), inset The
deactivation kinetics was assessed by fitting a two-exponential function to deactivating (“tail”) currents (red arrow), calculating the weighted average time constant as
shown in methods (tDEACT), and plotting tDEACT as a function of the activating-pulse potential amplitude (VACT). Example of a tDEACT-VACT plot is showed that
deactivation speed decreased as VACT was more positive. (B) Co-expressing the chimeric voltage-sensitive phosphatase Ci-VS-TPIP accelerated the deactivation of
the K+-current (red arrow). (B, inset) tDEACT-VACT plot showed that activation of Ci-VS-TPIP increased the speed of deactivation. (C) Voltage dependence of
activation was assessed by plotting the amplitude of deactivating current (ITAIL) normalized by its maximum value (ITAIL,MAX). (D) Similar plot than on C. However, ITAIL
was normalized by the amplitude of the tail current recorded following an activating pulse to −10 mV (ITAIL,−10mV).
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overall tendency of the deactivation kinetics was to slow down as a
function of tPULSE. An obvious pattern among t1, t2 and the fraction
of t2 that could clearly pinpoint any mechanistic underpinnings of
this process was not identified. This was not surprising as the two-
exponential function used was not derived from a comprehensive
kinetic model for activity of this channel. Therefore, to facilitate the
interpretation of the data, it was decided to merge these kinetic
parameters into a single measure, so generating a tDEACT-vs-tPULSE
plot (Figures 2F, J). These new plots showed the same trend
discussed above for t1 and t2 with tDEACT increasing with tPULSE
in two phases. These observations strongly suggest that the open
channel became harder-to-close as remained open. These results
were consistent with the idea that KV7.2/KV7.3 channels undergo a
transition from the activated/open channel into a more stable
conducting configuration.
Next, equivalent recordings were performed from oocytes co-
expressing Ci-VS-TPIP (Figure 2B). Again, it was observed from the
fit of the two-exponential function to the deactivating currents that
both t1 and t2 also increased as a function of tPULSE in these oocytes
(Figures 2C, D, red circles). However, both time constants tended to
be smaller than those observed for the channel expressed alone only
when the activation was prolonged. These findings indicated that the
action of Ci-VS-TPIP has a stronger effect on K+-current
deactivation when activation is prolonged. Accordingly, the
difference between t1 and t2 from oocytes co-expressing the
phosphatase and those expressing the channel along were greater
as tPULSE was longer, indicating that the effect of PI(4,5)P2 depletion
was more prominent as activation persisted. In fact, t1 values were
significantly smaller only for tPULSE was larger than 454 ms (p < 0.01,
d.f. = 21) (Figures 2C, G). Likewise, t2 values were significantly
smaller than those in control oocytes for tPULSE longer than 568 ms
(p < 0.05, d.f. = 21) (Figures 2D, H).
The trend of the fraction of t2 from oocytes co-expressing Ci-
VS-TPIP was not significantly different than that from oocytes
expressing the channels alone (Figures 2E, I) (p > 0.05, d.f. = 21).
This indicated that the relative contribution of each component
remained unaltered by the action of the phosphatase. Given these
results, no clear pattern in the three kinetic parameters pointed at
any specific mechanism underlying the decrease in the rate of
deactivation. Therefore, as before, the kinetic parameters were
consolidated into a single one. The calculated tDEACT from
oocytes co-expressing Ci-VS-TPIP were significantly smaller only
for tPULSE longer than 186 ms (p < 0.01, d.f. = 21) (Figures 2F, J).
This indicated that the effect of Ci-VS-TPIP was more prominent
when activation was prolonged, suggesting the stabilization of the
open channel was more sensitive to PI(4,5)P2 depletion.
Wortmannin Hinders the Decrease in the
Deactivation Rate of the KV7.2/KV7.3
Channel
One caveat to our interpretation above emerges from the fact
that the effect of Ci-VS-TPIP may be due to the voltage- and
time-dependence action of this phosphatase. Although the
voltage-dependent activity of Ci-VS-TPIP can be observed at
A B
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FIGURE 2 | Co-expression of Ci-VS-TPIP accelerates the deactivation kinetic of KV7.2/KV7.3 channels. (A) K
+-current recorded from Xenopus oocytes expressing
KV7.2/KV7.3 channels were activated by applying +40-mV pulses of variable duration from a H.P. set at −90 mV. Deactivation was then driven at −90 mV (red
arrow). (B) Equivalent recordings were performed from oocytes co-expressing Ci-VS-TPIP. In these recordings, the amplitude of K+-currents slowly decayed during
activation. This was expected because the activating +40-mV pulse further activates Ci-VS-TPIP, decreasing the PI(4,5)P2 concentration in the membrane. (C, D) A
two-exponential function was fitted to the deactivating currents and the resulting time constants for the first (t1) and second (t2) components of the function were
plotted against the duration of the +40-mV activating pulse (tPULSE) in the absence (black open squares, n = 8) or presence of Ci-VS-TPIP (red open circles, n = 13).
(E) Plot of the relative contribution of the second component of the two-exponential function (fraction of t2) versus tPULSE in the absence (black open squares, n = 8)
or the presence of Ci-VS-TPIP (red open circles, n = 13). (F) Weighted average time constant (tDEACT) plotted against tPULSE in the absence (black open squares,
n = 8) or the presence of Ci-VS-TPIP (red open circles, n = 13). (G–J) Semi-logarithmic version of the plot in (C–F), detailing tDEACT for tPULSE up to 1 s. the Arrows
in panel (C, D, F–H, J) indicate the range of tPULSE values at which values were statistically different.
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voltages as negative as −80 mV (Halaszovich et al., 2012), it is
possible that the lack of effect on the deactivation kinetics
following short tPULSE is due to low enzymatic activity of this
phosphatases, so producing a modest PI(4,5)P2 depletion. To
address this issue, an alternative approach to decrease PI(4,5)P2
in the membrane was employed, treating oocytes with the wide-
spectrum phosphoinositide kinase inhibitor Wortmannin. This
molecule is a furanosteroid isolated from the fungus Talaromyces
wortmannii (Nakanishi et al., 1992). Although it is a potent
inhibitor of PI-3-kinase, Wortmannin also inhibits
phosphoinositide 4-kinase at concentrations at the micromolar
range (Nakanishi and Catt, 1995). Because of this, Wortmannin
has been shown to effectively decrease the concentration of PI
(4,5)P2 in the plasma membrane (Suh and Hille, 2002; Zhang
et al., 2003; Hirdes et al., 2004; Bernier et al., 2008a; Bernier et al.,
2008b; Rodriguez-Menchaca et al., 2012; Dickson et al., 2014;
Tang et al., 2015; Kirchner et al., 2017).
Oocytes expressing KV7.2/KV7.3 channels were incubated in
10–20 μM Wortmannin for 30–60 min; the concentration of
Wortmannin varied depending on the sensitivity to the
treatment of each oocyte batch. As before, the H.P. was set at
−90 mV, K+-currents were activated by applying 1,200-ms pulses
with amplitudes ranging between −100 mV and +60 mV, and
deactivation was driven at −105 mV (Figures 3A, B). From these
recordings, the amplitude of the deactivating (“tail”) current was
plotted against the amplitude of the activation pulse (Figure 3C).
From these plots it was found that the voltage-dependence for
activation of the heteromeric KV7.2/KV7.3 was unaltered by the
treatment with Wortmannin (Figure 3C). However, as in the
case of co-expressing Ci-VS-TPIP, deactivation of K+-currents in
treated oocytes (Figure 3E) was faster than that of untreated
ones (Figure 3D). These observations were consistent with the
idea that channel deactivation was facilitated by reducing PI(4,5)
P2 concentration.
To further evaluate the effect of Wortmannin, K+-currents
were deactivated at −90 mV following activation by +40-mV
pulses of variable duration (Figures 4A, B). Fitting a two-
exponential function to the deactivating currents yielded t1
values that were significantly smaller than those from
untreated oocytes when tPULSE was longer than 200 ms (p <
0.01, d.f. = 22) (Figures 4C, G). In contrast, the values of t2 were
not significantly different between untreated and Wortmannin-
treated oocytes (Figures 4D, H). Yet, the fraction of t2 obtained
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FIGURE 3 | Effect of Wortmannin on the deactivation kinetics of KV7.2/KV7.3 channels. (A, B) Xenopus oocytes expressing KV7.2/KV7.3 channels were incubated
for 30–60 min with 10–20 mM of the PI-kinase inhibitor Wortmannin to decrease the concentration of PI(4,5)P2. Compared with untreated oocytes (A, red arrow), K+-
current deactivation was faster in oocytes treated with Wortmannin (B, red arrow). (C) Normalized ITAIL-VPULSE shown no difference in voltage-dependence between
untreated (n = 8) and treated oocytes (n = 13). (D, E) Examples of deactivating K+-currents from oocytes untreated (D) and treated (E) with Wortmannin. As on
Figure 1, deactivating K+-currents were fitted to a two-exponential function and the calculated tDEACT values were plotted against pulse potential (VPULSE, insets).
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significantly smaller with respect to those of untreated oocytes
for tPULSE longer than 200 ms (p < 0.05, d.f. = 22) (Figures 4E, I).
This suggested that the overall slowdown of the deactivation was
increasingly hindered by the action ofWortmannin as a function of
tPULSE. To test this idea, tDEACT were calculated and plotted with
respect to tPULSE (Figure 4F). As before, two phases were found:
One initial phase with rapid increase of tDEACT with respect to
tPULSE, and a second phase with a slower rate of increase of tDEACT.
The calculated tDEACT increased with tPULSE. However, these values
were smaller for Wortmannin-treated oocytes with respect to those
for untreated oocytes when tPULSE was longer than 291 ms (p <
0.01, d.f. = 22) (Figures 4F, J). Overall, these observations were
consistent with the finding that oocytes co-expressing Ci-VS-TPIP,
showing that the slowdown of the deactivation kinetics of KV7.2/
KV7.3 channels was impaired by either the action of the
phosphatase or by the treatment with Wortmannin. Therefore, it
is concluded that PI(4,5)P2 depletion has a higher impact on the
deactivation rate following prolonged activation.
PI(4,5)P2 Depletion Hampers the Activity-
Dependent Stabilization of Open Channels
by Retigabine
It is known that depletion of PI(4,5)P2 alter the interaction of M-
currents with drugs that promote their activity (Zhou et al.,
2013). Likewise, such drugs can partially compensate for the
decrease in M-currents caused by PI(4,5)P2 depletion (Zhou
et al., 2013). Retigabine stabilizes the channels’ open states as it
increases the dwell time of open events (Tatulian and Brown,
2003; Syeda et al., 2015). Consistently, Retigabine also decreases
the deactivation rate of KV7.2/KV7.3 channels (Main et al., 2000;
Linley et al., 2012; Corbin-Leftwich et al., 2016; Yau et al., 2018).
Furthermore, at the micromolar range of concentrations (<10
mM), Retigabine is more effective in decreasing the deactivation
rate when KV7.2/KV7.3 channels have been long activated or
when opened in steady state at typical neuronal resting potentials
(Corbin-Leftwich et al., 2016).
In the presence of 1 mM Retigabine, KV7.2/KV7.3 channels
display up to a two-fold increase in their deactivation time constant
when activated at +40 mV for at least 500 ms (Corbin-Leftwich
et al., 2016). However, activation with shorter pulses causes
negligible changes in the deactivation rate (Corbin-Leftwich et al.,
2016). This indicates that the action of Retigabine at low
concentrations on deactivation seems to require KV7.2/KV7.3
channels to be already activated and slowing down their
deactivation rate. On the other hand, here it has been found that
either co-expression of Ci-VS-TPIP or treatment withWortmannin
impairs the slowdown of the deactivation kinetics. This strongly
suggests that PI(4,5)P2 depletion would hamper the further
slowdown of the deactivation of KV7.2/KV7.3 channels induced
by Retigabine. To test this hypothesis, once again K+-currents were
recorded from oocytes co-expressing KV7.2/KV7.3 channels and the
chimeric Ci-VS-TPIP (Figure 5A). In the presence of 1 μM
Retigabine (Figure 5B), both t1 and t2 increased (Figures 5D, E,
blue open diamonds) and were larger than those fitted from
A B
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FIGURE 4 | Wortmannin treatment accelerates the deactivation kinetic of KV7.2/KV7.3 channels (A) As on Figure 2, K
+-current recorded from Xenopus oocytes
expressing KV7.2/KV7.3 channels were activated with +40 mV pulses of variable duration and then deactivated at −90 mV. (B) Equivalent recordings were performed
from oocytes treated incubated in 10 µM Wortmannin for 30–60 min. (C, D) The deactivating currents (red arrows in A, B) were fitted with a two-exponential function
and t1 and t2 were plotted against the duration of the +40-mV activating pulse (tPULSE) for untreated (black open squares, n = 8) or Wortmannin-treated oocytes (red
open circles, n = 14). (E) Relative contribution of the second component of the two-exponential function (fraction of t2) versus tPULSE for untreated (black open
squares, n = 8) or treated oocytes (red open circles, n = 14). (F) Weighted average time constant (tDEACT) plotted against tPULSE untreated (black squares, n = 8) or
treated oocytes (red circles, n = 14). (G–J) Semi-logarithmic version of the plot in (C–F), detailing tDEACT for tPULSE up to 1 s. Arrows in panel (C, E–G, I, J) indicate
the range of tPULSE values at which values were statistically different.
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recordings in the absence of the drug (Figures 5D, E, red solid
circles). However, the values of t1, t2, and the fraction of t2 were all
smaller or equal than those observed in oocytes expressing the
channels alone (Figures 5D, E, F, black solid squares). This
indicated that the stabilizing effect of Retigabine was mitigated by
the action of the phosphatase. In order to see the slowdown of the
deactivation induced by Retigabine, the concentration of the drug
was increased to 5 μM (Figure 5C). Under this condition, both t1
and t2 increases and were larger than those observed from oocytes
expressing channels alone. With respect to oocytes co-expressing
the phosphatase and in the presence of 1 μM Retigabine, both t1
and t2 were significantly larger for tPULSE longer than 888 and 363
ms, respectively (both: p < 0.01, d.f. = 11) (Figures 5D, E, G, H, red
open hexagons). The fraction of t2 was also significantly higher for
5 μM with respect to 1 μM Retigabine when tPULSE was 232 ms or
larger (p < 0.05, d.f. = 11) (Figures 5F, I, red open hexagons).
Overall, these observations indicated that PI(4,5)P2 depletion
impaired the slowdown of the deactivation induced by
Retigabine. To summarize these observations, tDEACT-vs-tPULSE
plots were generated (Figure 6A), showing tDEACT were
significantly higher in the presence of 5 μM Retigabine with
respect to 1 μM of the drug when tPULSE were larger than 61 ms
(p < 0.01, d.f. = 11) (Figure 6B). This reinforce the idea that PI(4,5)
P2 depletion impairs the action of Retigabine, particularly when
channels have been activated for longer periods of time.
To further test the idea that PI(4,5)P2 modulates the action of
Retigabine, recordings were performed from oocytes expressing
KV7.2/KV7.3 channels alone and treated with Wortmannin. In
this case, a similar pattern emerged than with the co-expression
of Ci-VS-TPIP. Although the slowdown the deactivation of the
KV7.2/KV7.3 of Wortmannin-treated (Figures 6C, D, red solid
circles) was boosted by 1 μM Retigabine (Figures 6C, D, blue
open diamonds), it was not larger than that observed in
untreated oocytes (Figures 6C, D, black solid squares). Only
increasing the concentration of Retigabine to 5 μM produced a
significant slowdown in the deactivation kinetics (Figures 6C, D,
red open hexagons) larger than that in untreated oocytes
(Figures 6C, D, black solid squares). These combined
observations indicated that the action of the Retigabine can be
counteracted by either the action of Ci-VS-TPIP or the treatment
with Wortmannin. This led to the conclusion that the action of
Retigabine on the deactivation kinetics is strongly modulated by
PI(4,5)P2, particularly following prolonged activation.
DISCUSSION
Here, it has been shown that either the co-expression of Ci-VS-
TPIP or the treatment with Wortmannin had an unambiguous
effect on the kinetics of deactivation when it followed prolonged
activation. Consistent with previous reports, it seems that KV7.2/
KV7.3 channels undergo a process of stabilization of their
activated/open conformation when they are activated for
prolonged periods of time. In addition, this underlying process
for stabilization seems to require PI(4,5)P2. This is consistent with






FIGURE 5 | PI(4,5)P2 regulates the action of Retigabine. (A–C) K
+-currents were activated with a +40 mV pulses of variable duration in Xenopus oocytes expression
KV7.2/KV7.3 channels. Subsequently, the currents were deactivated at −90 mV. These recordings were performed in the absence (A) and the presence of 1 µM (blue
diamonds, n = 6) and 5 µM of Retigabine (red triangles, n = 7) (C). (D–F) A two-exponential function was fitted to deactivating currents and the yielded t1, t2 and the
fractional contribution of the second component (fraction of t2) were plotted against tPULSE. (D–F, respectively). (G–I) Semi-logarithmic version of the plot in (D–F),
detailing tDEACT for tPULSE up to 1 second. For reference, the equivalent values from Figure 2 were plotted as small black square and small red circles. Black arrows in
panels (D–I) indicate the range of tPULSE values at which values were statistically different between the recordings in the presence of 1 µM and 5 µM Retigabine.
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unambiguous decrease in the deactivation rate when co-expressed
with the phosphoinositide kinase PI5K, indicating that increasing
the concentration of PI(4,5)P2 slowdown deactivation (Chen et al.,
2015). Yet, it has been shown no change in the deactivation
kinetics of M-currents upon application of Muscarine in trypsin-
digested isolated bullfrog lumbar sympathetic ganglia (Adams
et al., 1982). It is not clear what the reason for this discrepancy is.
However, it is to be considered that other factors are in play when
studying M-currents in a native system. For instance, in neurons
for a sympathetic ganglion, Muscarine activate muscarinic
GqPCRs that degrades PI(4,5)P2 into DAG and IP3, so
increasing the concentration of Ca2+ through IP3 receptors. As
Ca2+ is known to modulate M-currents, decreasing their
deactivation rate (Yu et al., 1994), it is possible that the
apparent discrepancy mentioned here arises from a combination
of factor playing in the native system.
Another aspect to be considered is the potential effect of PI(4)P
when produced by Ci-VS-TPIP after dephosphorylating PI(4,5)P2.
Although the experiments reported here cannot tell what the effect
of PI(4)P would be on the activity of KV7.2/KV7.3 channels,
previous reports have shown that the conversion of PI(4,5)P2 into
PI(4)P by Ci-VSP and Dr-VSP render the channels inactive
(Murata and Okamura, 2007; Villalba-Galea et al., 2009; Kruse
et al., 2012). So, in principle, it is unproven, yet reasonable to assume
that PI(4)P is ineffective in sustaining the activity of KV7.2/KV7.3
channels. Consistently, it has been shown that the PI(4)P-analog
diC8PI(4)P is has a lower potency than the PI(4,5)P2-analog diC8PI
(4,5)P2 to sustain M-current activity (Telezhkin et al., 2012b).
An additional consideration is related to the ability of oocytes
to either regenerate or maintain PI(4,5)P2 levels. To this, it is
important to consider that the current implementation of the
COVC technique relies on making a chemical “perforation” in a
restricted and small area of the oocyte’s plasma membrane using
a mild detergent treatment (Saponin, 0.1% in intracellular
recording solution). Thus, the oocytes conserved its integrity.
Even when expressing VSPs in oocytes, PI(4,5)P2 can be
degraded by over and over again as the oocyte regenerates as
evidenced by the recovery of the current as VSP deactivation
(Villalba-Galea et al., 2009; Halaszovich et al., 2012).
A final consideration on the use of VSPs is the potential effect
that they can have on channel activity their enzymatic properties.
It has been shown that the inactivated chimeric Ci-VS-TPIP-
C363S affects the activation of KV7.4 channels expressed in
Chinese Hamster Ovary (CHO) cells (Halaszovich et al., 2012).
This suggests that it is possible that there is interaction between
these proteins. Although this issue was not directly addressed in
the present study, the activation of KV7 channels in oocytes co-
expressing Ci-VS-TPIP did not display any obvious differences
with respect to the activation in oocytes expressing the channels
alone. Example of that can be seen in Figure 1.
Modal Behavior
The work presented here reinforces the idea that this heteromeric
channel displays at least two modes of activity once activated. A
first mode that is reached immediately upon activation and a
second mode that is reached once activation has been prolonged.
Further, the second mode of activity seems to be more stable than
the first one because deactivation is slower from it. Furthermore,
it was shown that PI(4,5)P2 depletion has a relative stronger
effect on deactivation as channels are activated for longer periods
of time. This suggests that KV7.2/KV7.3 channels in their second
mode of activity are more sensitive to PI(4,5)P2 depletion.
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FIGURE 6 | Overall deactivation kinetics as a function of the tPULSE. (A) As before, to consolidate the analysis of the deactivation kinetics, tDEACT was plotted against
the duration of the +40-mV Pulse (tPULSE) for currents recorded in the presence of 1 mM and 5 mM Retigabine (blue open diamonds and red oepn hexagons,
respectively). (B) The values of tDEACT were significantly different for tPULSE longer than 61 ms. For reference, the equivalent values from Figure 2 were plotted as
black solid square and red solid circles. (C, D) Equivalent tDEACT-tPULSE plots generated from Wortmannin-treated oocytes.
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Modal gating has been documented in the activity of many
types of channels and it has been shown to be critically involved
in their function (Nilius, 1988; Marrion, 1993; Naranjo and
Brehm, 1993; Zahradnikova and Zahradnik , 1995;
Zahradnikova et al., 1999; Magleby, 2004; Tanskanen et al.,
2005; Chakrapani et al., 2011; Bicknell and Goodhill, 2016). To
understand modal gating, it is essential to define what a “mode”
is. In theory, a “mode” constitutes a cluster of interconnected
states (typically open and closed) in which a channel dwells for a
certain period of time until it transitions to a state belonging to
another cluster (Fill et al., 2000). A mode can be seen as “bursts”
or “trains” of repetitive opening and closing events. These bursts
share similar open probability and lifetimes of open and close
channel events. So, a channel can sojourn in one mode and
eventually transition into a different mode, changing their open
probability and/or events’ lifetime.
One well-documented case of modal gating is the one
observed in the activity of the Ryanodine Receptor type 2
(RyR2) (Gyorke and Fill, 1993; Zahradnikova and Zahradnik,
1995; Zahradnikova et al., 1999; Fill et al., 2000). These Ca2
+-activated channels have at least two modes of open channel
activity which are known as the high open probability (HPo)
and the low open probability (LPo) modes. Interestingly, RyR2
generally opens into their HPo mode when activated by a rapid
increase in Ca2+ concentration (Gyorke and Fill, 1993). Then,
RyR2 starts reversibly sojourning between modes. When
reaching a steady state, HPo and LPo modes are both populated
in a Ca2+-dependent manner, effectively decreasing the overall
open probability (Gyorke and Fill, 1993; Zahradnikova and
Zahradnik, 1995; Zahradnikova et al., 1999; Fill et al., 2000).
Because the HPo mode is first reached, the activity of RyR2 is
always higher immediately after activation with respect to steady
state (Zahradnikova et al., 1999; Fill et al., 2000). This is the basis
for what is known as “RyR adaptation” which is critical for the
control of Ca2+-induced Ca2+ Release in cardiac myocytes
(Gyorke and Fill, 1993; Zahradnikova et al., 1999).
Modal gating is also observed in the activity of the bacterial
potassium-selective channel KcsA. This channel displays three
modes, namely, High Po, Low Po, and Flickering modes
(Chakrapani et al., 2011). Interestingly, mutation of the residue
E71 in the selectivity filter of KcsA can strongly modulate the
likelihood of observing these modes and their kinetics
(Chakrapani et al., 2011). Modal gating is the underlying
process of slow inactivation in the activity of KcsA.
For RyR2, KcsA, and some neuronal receptors such
acetylcholine and NMDA receptors that undergo desensitization
(Nilius, 1988; Magleby, 2004; Bicknell and Goodhill, 2016), modal
gating is correlated with the decrease of channel activity as
activation is prolonged. However, this is not the case in KV7
channels. Modal activity in the heteromeric KV7.2/KV7.3 channels
seems to increase or stabilize their activity as deactivation becomes
slower as activation persists.
Modal Behavior and KV7 Pharmacology
The idea of modal gating in the activity of KV7 channels was first
introduced by N.V. Marrion in 1993, and other subsequently
(Marrion, 1993; Selyanko and Brown, 1999). At the single
channel level, it has been found that M-currents can display
two types of “activity bursts” that where distinguished by their
open probability and the lifetime of their open channel events.
This observation showed for the first time that KV7 channels can
operate in more than one mode.
It has been shown from single channel recordings of M-
currents that the frequency of longer-living open channel events
decreases upon the application of Muscarine (Marrion, 1993).
This indicates that modal gating is modulated by PI(4,5)P2.
Consistently, we observed here that the slowdown of the
deactivation is impaired following PI(4,5)P2 depletion. This
strongly suggest that the modal behavior can be targeted by PI
(4,5)P2 regulation.
The slowdown of the deactivation is here referred to in terms
of “modal behavior” or “modal activity”. These terms have been
intentionally used to make a distinction with the concept of
“modal gating”. This is because single channel analysis escapes
the scope of the present study and is yet-to-be correlated with the
change in the deactivation kinetics. Nonetheless, the fact that
deactivation becomes slower strongly suggests a modal transition
in the activity of these channels as activation is sustained.
Supporting the idea of modal activity in KV7.2/KV7.3 channel
is the observation that Retigabine has a stronger impact on
deactivation as they are kept activated. Furthermore, this study
has shown that PI(4,5)P2 depletion also displays a differential
effect, having a higher impact on deactivation after prolonged
activation. These kinetic, pharmacological, and regulatory types
of evidence strongly support the notion of modal activity in
KV7.2/KV7.3 channels.
PI(4,5)P2 and KV7 Modal Behavior
The molecular basis for the apparent differential modal
sensitivity of the deactivation rate to PI(4,5)P2 depletion is yet-
to-be defined. However, there are at least two alternatives worth
discussing. One is that, since the homomeric KV7.2 and KV7.3
channels have distinct affinities for PI(4,5)P2 (Delmas and
Brown, 2005; Telezhkin et al., 2012a), it is possible that the
differential modal sensitivity to PI(4,5)P2 depletion emerges from
the distinct affinities of the subunits. If this was the mechanism, it
would imply that the action of PI(4,5)P2 in activation and
stabilization of the open conformation of the channels would
depend on the subunit that this lipid is bound to. An alternative
option is based on the existence of multiple binding sites for the
PI(4,5)P2 within each subunit of the KV7.2/KV7.3 channel
(Zhang et al., 2003; Loussouarn et al., 2003; Hernandez et al.,
2008b; Hernandez et al., 2009; Thomas et al., 2011; Telezhkin
et al., 2012b; Telezhkin et al., 2013; Chen et al., 2015). In this case,
the role of PI(4,5)P2 in the processes of activated/open channel
stabilization will depend on which binding site is bound to. In
this case, the affinity to the binding involved in stabilization
would be lower than other sites as stabilization was shown to be
more sensitive to PI(4,5)P2 depletion. The idea that distinct
binding sites have different roles in activation and deactivation
is consistent with a previous report suggesting PI(4,5)P2 switches
position during activation, migrating from the S2-S3 linker to the
S4-S5 linker (Chen et al., 2015).
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The first putative mechanism implies that inter-subunit
differences in affinity are responsible for the increased
sensitivity to PI(4,5)P2 depletion. The second mechanism
implies that multiple sites within each subunit play distinct
role in activation and stabilization. Although the approach
taken in this study does not allow discriminating between the
first inter-subunit and the second intra-subunit multiple-site
models, one important distinction between the two models is
that the first one would predict that homomeric channels may
not display modal behavior. To provide an initial approximation
to addressing this issue, K+-currents were recorded from
Xenopus oocytes expressing the homomeric KV7.2 channel. As
for the heteromeric channel, the H.P. was set at −90 mV,
channels activated by 1,200-ms pulses ranging from −100 to
+60 mV, and then deactivated at −105 mV (Figure 7). As
expected, deactivation of the K+-currents was slowed down by
Retigabine (Figures 7A, B, red arrow). At this low concentration
of RTG, under the conditions the recordings were made, a
negligible shift in the KV7.2 channel’s voltage-dependence of
activation was observed toward negative potential. Next, the
effect of activation on deactivation was evaluated by activating
the channels with +40-mV pulse of variable duration, following
with deactivation at −90 mV (Figure 8A). As before, tDEACT
values were calculated and plotted against the duration of the
activating pulse (tPULSE) (Figure 8C, black open squares). Like
for the heteromeric KV7.2/KV7.3 channel, tDEACT-tPULSE curves
exhibited two clear phases in the slowdown of the deactivation of
the homomeric KV7.2 (Figure 8C, black open squares). Addition
of 10 μM Retigabine induced an increase in the time constant of
deactivation (Figure 8B). As before, tDEACT for short activation
pulses (<36 ms) were unaffected by 10 μM Retigabine (p < 0.01,
d.f. = 15) (Figures 8C, D, red open circles). These observations
led to conclude that the homomeric KV7.2 channel also displays
at least two modes of activity, implying that modal behavior is
intrinsic of each subunit—or at least of the KV7.2 subunit—and
not arise from it being a heteromeric protein.
Molecular Basis for Modal Behavior in
KV7 Channels
Consistent with previous studies (Linley et al., 2012; Kim et al.,
2017), results from in the present study show that Retigabine was
able to overcome the effect of the partial depletion of PI(4,5)P2 in
the activity of KV7.2/KV7.3 channels. In addition to this
observation, a novel finding was that both the effect of
Retigabine and the effect of PI(4,5)P2 depletion are more
prominent following prolonged activation. This led to the
conclusion that the modal behavior of KV7.2/KV7.3 channels is
modulated by both Retigabine and PI(4,5)P2.
Retigabine binds to the channel’s pore, implying that that its
effect is likely mediated by this domain. Thus, one emerging
question is: what is the mechanism for mode switching? It has
been proposed that both the VSD and the pore of channels can
display hysteretic behavior (Villalba-Galea, 2017). Hysteresis is a
property of physical and chemical systems in which the response
of such system to an external force or field depends on the




























FIGURE 7 | K+-currents from oocytes expressing KV7.2 channels, before (A) and after adding 10 mM RTG (B). The current deactivation slowed down in the
presence of the drug (red arrows). (C) Deactivation current amplitude (ITAIL) were normalized respect the largest current amplitude (ITAIL,MAX). The average of the
normalized currents were plotted versus the activating voltage (n = 15).
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have a defined voltage-dependence. However, a growing body of
evidence shows that voltage dependence is dynamic an
dependent on activity itself (Villalba-Galea, 2017). The
response to changes in the membrane potential has been
shown to be activity-dependent in channels such as Shaker
(Lacroix et al., 2011), HCN (Mannikko et al., 2005; Elinder
et al., 2006; Bruening-Wright et al., 2007; Xiao et al., 2010),
KV3.1 (Labro et al., 2015), NaV (Bezanilla et al., 1982), and KcsA
(Tilegenova et al., 2017), among others. For voltage-gated
channels, hysteresis typically manifests as a shift in voltage-
dependence toward negative potentials, a decrease in the
deactivation rate, or both (Corbin-Leftwich et al., 2016). This
implies that activation and deactivation follow distinct pathways
or sequence of events. In the case of KV7.2/KV7.3, deactivation is
initially fast, slowing down as the channels remain activated. This
indicates that a transition to a more stable open mode of activity
occurs as activation persists, implying that deactivation follows a
distinct path toward resting states.
A minimal voltage-gated channel is composed of a pore
domain and four voltage-sensing domains. So, the question is,
which of these domains may cause modal or hysteretic behavior
in a channel? Although this question is yet to be answered, there
is evidence suggesting that action of both domains can drive
these behaviors. For instance, a recent study shows that the
bacterial K+-channel KcsA can display hysteresis in its activation.
This hysteretic behavior is manifested as a shift in their pH
dependence for activation (Tilegenova et al., 2017). This means
that the affinity for hydrogen ions depends on whether the
channel is activated or deactivated (Tilegenova et al., 2017).
This study suggests, therefore, that an “isolated” pore can exhibit
hysteresis. On the other hand, the voltage-dependence for
sensing charge movement of an “isolated” VSD can change as
a function of activity, shifting to more negative potential
following activation (Villalba-Galea et al., 2008) and/or making
deactivation slower (Labro et al., 2012). At this point, it cannot be
established if any of these fundamental mechanisms—or any
other—is ultimately responsible for modal behavior or hysteresis
in the activation of KV7.2/KV7.3 channels. However, changes in
the deactivation rate induced in this study with enzymatic and
pharmacological means show a more prominent effect of
deactivation, virtually sparing voltage-dependence. This
suggests that conformational rearrangements in the pore
domain might be a key factor in the modal behavior of
KV7 channels.
Here, it was shown that there is a link between the regulation
by PI(4,5)P2 and modal behavior of the KV7.2/KV7.3 channel.
A C
B D
FIGURE 8 | To determine whether the decrease in the rate of deactivation was a unique property of the heteromeric KV7.2/KV7.3 channel. (A, B) K
+-current
recordings from oocytes expressing KV7.2 in the absence and presence of 10mM Retigabine (RTG). (C) tDEACT was plotted as a function of tPULSE for the homomeric
KV7.2. It was found that the slow down of the deactvation kinetics still occurs when KV7.2 was expressed alone, suggesting that the hysteretic behavior of these KV7
channels was not a property emerging from heteromerization (n = 5). (D) tDEACT-tPULSE plots in C, replotted with a logarithmic tPULSE to highlight the behavior of
tDEACT at short tPULSE values.
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This suggests that GqPCR-mediated modulation may target KV7
channel modal behavior. Since the action of Retigabine was also
strongly dependent on modal activity, it can be concluded that
GqPCR activity is likely an important modulator of KV7
channel’s pharmacology.
Retigabine-Induced Shift in Voltage
Dependence
Except for KV7.1 channels, it has been commonly reported that
retigabine induces a shift in the voltage-dependence for
activation of KV7 channels, facilitating opening. Under the
experimental conditions used in the present study, low
concentrations of retigabine (≤10 μM) were able to induce
shifts in the voltage dependence for activation of KV7.2 and
KV7.2/KV7.3 channels that were smaller than those reported
elsewhere. There is not clear explanation for such discrepancy.
Yet, there are some considerations that may help explaining it.
First, most of the papers reporting the effect of retigabine on KV7
channels expressed in oocytes have used the Two-Electrode
Voltage-Clamp (TEVC) technique. Employing this technique,
we observed in my lab similar shifts in the conductance-vs-
voltage (G-V) curves of KV7.2/KV7.3 channels that resembled
those reported in the literature. We also observed a large
variability in the magnitude of the shift. Furthermore, we
noted that the washout of the drug allowed the return of the
G-V curve to more positive voltages, but deactivation remained
slower. This led us to hypothesize that the variability observed
was due to limitation of the TEVC technique (Baumgartner et al.,
1999) which was likely exacerbated by the slow deactivation
kinetic of the channels. So, it was then decided to change our
approach and employ the COVC technique because it offers
better space and temporal control of the membrane potential
(Taglialatela et al., 1992; Stefani and Bezanilla, 1998). Regretfully,
we did not perform further investigation of the issue.
Another important consideration is that the slow kinetic of
KV7 channels constitutes a challenge in itself when studying slow
transition in channel behavior. In this and in our previous study
(Corbin-Leftwich et al., 2016), 1 μM of retigabine increased the
average deactivation time constant of KV7.2/KV7.3 channels to
approximately 600 ms at −90 mV when following an activating
+40-mV pulse of 2 s in duration. This was almost twice the time
needed for the channels to close in the absence of the drug.
Assuming an exponential deactivation process, a 600-ms time
constants means that 3 s was the minimum time required to
reach 99% of channel closure. Further, 5 μM of retigabine caused
an additional doubling of the deactivation time (Corbin-Leftwich
et al., 2016), implying the need of 6 s to allow channels to close.
Furthermore, these estimated deactivating times may be even
longer if considering that channel closure does not imply full
deactivation, as deactivation also involves transition through
closed states (Zagotta et al., 1994). Some published studies
have used protocols with H.P.s at −80 mV and deactivating
potentials at −30/−40 mV. We have observed deactivation time
constants of up to 2.5 s at −80 mV in the presence of 1 μM
retigabine (Corbin-Leftwich et al., 2016). This indicates that
closure could take at least 12 s at such potentials. Being very
cognizant of this notion, recordings were performed for the
present study providing long periods of time to allow channels to
fully deactivate. For instance, 10 s or more for channels to
deactivate at −105 mV (Figures 1, 3, and 7) and at least 16 s
when deactivating at −90 mV (Figures 2, 4, 5, and 8). It is
noteworthy that this is not uncommon feature of channels held
active for a long time. For instance, channels like Shaker, which is
“very fast channels”, can take seconds to fully deactivate (Lacroix
et al., 2011). Therefore, we speculate that the source of
discrepancy between this and other studies may emerge from
differences in the pulse protocols used. Deactivation time
constants and periods of recovery are to be carefully designed
during electrophysiological studies using voltage-clamp techniques.
Modeling the Activity of KV7.2 Channels
Five models for the activity of KV7.2 were evaluated (Figure 9A).
Models “00” and “0” cannot display modal behavior as they are
based on unbranched, sequential kinetic schemes. Models A, B,
and C may display modal behavior depending on the rates.
Transition in the horizonal direction have rates names a and b
which were considered to be functions of the voltage. Transitions
in the vertical direction have rates named g and d which were
considered voltage-independent for simplicity.
Using a framework for analysis previously developed
(Villalba-Galea, 2014), each model was simultaneously fitted to
activating and deactivating currents recorded from an oocyte
expressing KV7.2 channels (Figure 9B). Activation was driven
from a H.P. of −90 mV by voltage pulses with amplitudes ranging
from −50 to +40 mV. The deactivation was driven at −90 mV,
following +40-mV pulses of increasing duration, ranging from
48 to 4,235 ms. The quality of the fit was assessed by calculating
the square difference (SD) between the recording and the fitted
traces. For each model, five trials with randomly seeded
parameters were used to initialize the fitting. Then, five trials
were seeded with the average parameters obtained from the
initialization step and let run to obtain the final fitted parameters.
The fitted models shown here are part of an ongoing study. In
this phase of that study, model B has been the best fitted model
according to calculated SD values (Figure 9C). This is likely due
to the larger number of parameters in model C which requires
larger number of iterations.
The fitted parameters for model B showed that the rates
between states C0 through C4 are strongly voltage dependent
(Figure 10B). Accordingly, about 1.6 electron-charges per
subunit are associated to these transitions, accounting for 96%
of the total sensing charges of the model. On the other hand,
transitions between states C4, O1, and O2 display low voltage-
dependence, accounting for the remaining 4% of sensing charges.
Another important finding is that the transition rates gC4, dC4,
gO1, and dO1 were at least one order of magnitude smaller than
gC3, dC3, gO2, and dO2 (Figure 10A). This made the transitions
between C4 and C4s and between O1 and O1s very unlikely. In
addition, given the value of za1 and the transition coefficient a1,
the rate of transition from C3 to C4 at +40 mV would be three
times larger than gC3 which is the transition rate from C3 to C3s.
Further, aO1 was more than three times a1s, implying that the
transition from C4 to O1 would readily “drain” the state C4,
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FIGURE 9 | (A) Kinetic models considered to describe the activity of KV7.2 channels. (B) Example of fitted currents data (red traces) overlapping experimentally recorded





























































































































































































































FIGURE 10 | Fitted parameters for model B. (A) Rate coefficients for transitions. (B) Elementary charges associated to the transtion. (C) Simplification of the model
B based on the rates. Blue arrows indicate preferred direction immediately after activation (green arrow) and during deactivation following prolonged activation botton
(red arrow).
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effectively increasing the transition rate from C3 to C4.
Furthermore, gO2 was higher than dO2. This led to conclude
that there is a preferred direction in the model, having state O2
being populated first following activation and with state O2s
being populated as the activation is prolonged. It is important to
note that the preferred direction does not violate the micro-
reversibility principle. In fact, micro-reversibility was checked at
every step of the fit (between 50,000 and 150,000 iterations per
trial). From this preliminary study, model B was simplified into
an “interpreted” (or effective) model B (Figure 10C). The
interpreted model B is consistent with the existence of two
modes in the activity of KV7.2 channels.
A Final Thought on the Use of a Two-
Exponential Function for Quantifying
Changes in the Deactivation Kinetics
As in previous studies on the activity of KV7 and other KV
channels (Wickenden et al., 2000; Labro et al., 2012; Priest et al.,
2013; Labro et al., 2015; Corbin-Leftwich et al., 2016), this
function was chosen because it is able to tightly trace the
deactivation of the K+-currents studied here. It is important to
stress that the use of a two-exponential function does not mean
that the model has two states or modes or ways to be activated or
deactivated. This is a misconception that is commonly adopted.
Strictly speaking, the number of components in a function
describing the behavior of a channel will be equal to the total
number of kinetics states (Villalba-Galea, 2014). Thus, if a
channel has one closed and two open states, then the number
of components should be three. I believe that it is unarguable that
channels like those of the KV family have multiple states—say, at
least five closed (given that they have four VSDs) and one open
(Zagotta et al., 1994). This means that the minimum number of
components should be 6, with one of the exponents being zero.
When fitting the kinetics of deactivation, this will involve fitting
10 kinetic parameters, namely, time constant and amplitude of
each component, plus the baseline (which is the pre-exponential
value of the zero-exponent term) (Zagotta et al., 1994; Villalba-
Galea, 2014). This argument should suffice to make the point
that, beyond the simple temporal description of the deactivation,
interpreting the four kinetic parameters yielded by fitting the
data to a two-exponential function is inadequate as it contains
insufficient information. Furthermore, this is also the reason why
assigning physical meaning to these parameters can be
misleading and/or inadequate.
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